BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38742655)

  • 1. Soluble MIC-A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma.
    Vela-Ojeda J; Olivas-Bejarano AC; Montiel-Cervantes LA; Rosales-Cruz E; Garcia-Gutierrez S; Lezama-Palacios RA; Reyes-Maldonado E
    Eur J Haematol; 2024 May; ():. PubMed ID: 38742655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subsets and soluble forms of MIC-A and MIC-B are prognostic factors in non-Hodgkin lymphoma patients.
    Olivas-Bejarano AC; Montiel-Cervantes LA; Del Carmen Perez-Retiguin F; Garcia-Gutierrez S; Cruz-Hernandez TR; Lezama-Palacios RA; Reyes-Maldonado E; Vela-Ojeda J
    Ann Hematol; 2024 Apr; 103(4):1317-1325. PubMed ID: 38091053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant increase in MIC-A and MIC-B and soluble MIC-A and MIC-B in canine lymphomas.
    Lopez-Montaño M; Jimenez-Ortega L; Cruz-Hernandez TR; Hernandez-Chavez VG; Montiel-Cervantes LA; Reyes-Maldonado E; Vela-Ojeda J
    Vet Immunol Immunopathol; 2023 Oct; 264():110647. PubMed ID: 37672843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy.
    Hou H; Luo Y; Tang G; Zhang B; Ouyang R; Wang T; Huang M; Wu S; Li D; Wang F
    Cancer Cell Int; 2021 May; 21(1):282. PubMed ID: 34044841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma.
    Vela-Ojeda J; Perez-Retiguin FDC; Olivas-Bejarano AC; Garcia-Ruiz Esparza MA; Garcia-Chavez J; Majluf-Cruz A; Reyes-Maldonado E; Montiel-Cervantes LA
    Leuk Lymphoma; 2021 Apr; 62(4):801-809. PubMed ID: 33284055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
    Huang H; Fan L; Fu D; Lin Q; Shen J
    Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma.
    Yoon SE; Park S; Cho J; Ryu KJ; Yandava B; Lee S; Kim SJ; Kim WS
    Front Oncol; 2023; 13():1194315. PubMed ID: 38033491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy.
    Basher F; Dhar P; Wang X; Wainwright DA; Zhang B; Sosman J; Ji Z; Wu JD
    J Hematol Oncol; 2020 Jun; 13(1):74. PubMed ID: 32517713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma.
    Castro D; Beltrán B; Quiñones MDP; Pachas C; Huerta Y; Lalupu K; Mendoza R; Castillo JJ
    Leuk Res; 2021 Mar; 102():106513. PubMed ID: 33561632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing gammadelta T cell cytotoxicity.
    Märten A; von Lilienfeld-Toal M; Büchler MW; Schmidt J
    Int J Cancer; 2006 Nov; 119(10):2359-65. PubMed ID: 16929491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of total lesion glycolysis and cell-of-origin subtypes for prognostic stratification of diffuse large B-cell lymphoma patients.
    Jiang C; Teng Y; Zheng Z; Zhou Z; Xu J
    Quant Imaging Med Surg; 2021 Jun; 11(6):2509-2520. PubMed ID: 34079720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of metabolic tumour volume on baseline
    Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC
    Zhang J; Larrocha PS; Zhang B; Wainwright D; Dhar P; Wu JD
    J Immunother Cancer; 2019 Aug; 7(1):223. PubMed ID: 31446896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic model using the NCCN-IPI and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma.
    Go SI; Park S; Kim JH; Kim HR; Kim M; Moon K; Seo J; Lee GW
    Tumori; 2018 Aug; 104(4):292-299. PubMed ID: 29737944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Shin HJ; Kim DY; Chung J; Shin KH; Lee H
    Acta Haematol; 2021; 144(4):427-437. PubMed ID: 33271543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Nutritional Index Predicts Early Mortality in Diffuse Large B-cell Lymphoma.
    Ozturk E; Elibol T; Kilicaslan E; Kabayuka B; Erdogan Ozunal I
    Medeni Med J; 2022 Mar; 37(1):85-91. PubMed ID: 35306794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Level of Blood CD4
    Judd J; Dulaimi E; Li T; Millenson MM; Borghaei H; Smith MR; Al-Saleem T
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):83-88. PubMed ID: 28027895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Enhanced International Prognostic Index for Diffuse Large B-cell Lymphoma.
    Yang Y; Wang L; Ma Y; Han T; Huang M
    Am J Med Sci; 2017 May; 353(5):459-465. PubMed ID: 28502332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and therapeutic value of serum lipids and a new IPI score system based on apolipoprotein A-I in diffuse large B-cell lymphoma.
    Yu T; Luo D; Luo C; Xu-Monette ZY; Yu L
    Am J Cancer Res; 2023; 13(2):475-484. PubMed ID: 36895983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
    Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
    Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.